
James Schultz
Examiner (ID: 14322, Phone: (571)272-0763 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1631, 1635 |
| Total Applications | 977 |
| Issued Applications | 385 |
| Pending Applications | 182 |
| Abandoned Applications | 415 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4565756
[patent_doc_number] => 07846910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-07
[patent_title] => 'Pharmaceutical composition, composition for screening therapeutics preventing and treating beta amyloid accumulation in brain comprising GCP II (glutamate carboxypeptidase II) as an active ingredient and method for screening using the same'
[patent_app_type] => utility
[patent_app_number] => 12/064426
[patent_app_country] => US
[patent_app_date] => 2006-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 8253
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/846/07846910.pdf
[firstpage_image] =>[orig_patent_app_number] => 12064426
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/064426 | Pharmaceutical composition, composition for screening therapeutics preventing and treating beta amyloid accumulation in brain comprising GCP II (glutamate carboxypeptidase II) as an active ingredient and method for screening using the same | Aug 22, 2006 | Issued |
Array
(
[id] => 8554706
[patent_doc_number] => 08329175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders'
[patent_app_type] => utility
[patent_app_number] => 11/990803
[patent_app_country] => US
[patent_app_date] => 2006-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 11
[patent_no_of_words] => 28980
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11990803
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/990803 | Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders | Aug 17, 2006 | Issued |
Array
(
[id] => 8232646
[patent_doc_number] => 08198085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-12
[patent_title] => 'Somatic cells for use in cell therapy'
[patent_app_type] => utility
[patent_app_number] => 11/989929
[patent_app_country] => US
[patent_app_date] => 2006-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 15658
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/198/08198085.pdf
[firstpage_image] =>[orig_patent_app_number] => 11989929
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/989929 | Somatic cells for use in cell therapy | Aug 2, 2006 | Issued |
Array
(
[id] => 6486732
[patent_doc_number] => 20100093080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'Tooth Regeneration Method'
[patent_app_type] => utility
[patent_app_number] => 11/997077
[patent_app_country] => US
[patent_app_date] => 2006-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8384
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093080.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997077
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997077 | Tooth Regeneration Method | Jul 24, 2006 | Abandoned |
Array
(
[id] => 5515566
[patent_doc_number] => 20090215873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Therapeutic Molecules and their Uses'
[patent_app_type] => utility
[patent_app_number] => 11/992891
[patent_app_country] => US
[patent_app_date] => 2006-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27370
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215873.pdf
[firstpage_image] =>[orig_patent_app_number] => 11992891
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/992891 | Therapeutic Molecules and their Uses | Jul 17, 2006 | Abandoned |
Array
(
[id] => 4573042
[patent_doc_number] => 07824912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-02
[patent_title] => 'Methods for ex vivo propagation of adult hepatic stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/472238
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 30
[patent_no_of_words] => 19700
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/824/07824912.pdf
[firstpage_image] =>[orig_patent_app_number] => 11472238
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/472238 | Methods for ex vivo propagation of adult hepatic stem cells | Jun 20, 2006 | Issued |
Array
(
[id] => 8870962
[patent_doc_number] => 08466339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-18
[patent_title] => 'Mig-6 knockout mice and elucidation of association of Mig-6 with early onset degenerative joint disease and role as a tumor suppressor'
[patent_app_type] => utility
[patent_app_number] => 11/917557
[patent_app_country] => US
[patent_app_date] => 2006-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 25
[patent_no_of_words] => 18792
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11917557
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917557 | Mig-6 knockout mice and elucidation of association of Mig-6 with early onset degenerative joint disease and role as a tumor suppressor | Jun 14, 2006 | Issued |
Array
(
[id] => 5538777
[patent_doc_number] => 20090220582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'METHOD OF CANCER TREATMENT USING SIRNA SILENCING'
[patent_app_type] => utility
[patent_app_number] => 11/917593
[patent_app_country] => US
[patent_app_date] => 2006-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13167
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220582.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917593
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917593 | Method of cancer treatment using siRNA silencing | Jun 14, 2006 | Issued |
Array
(
[id] => 10031476
[patent_doc_number] => 09072776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Anti-cancer combination treatment and kit-of-parts'
[patent_app_type] => utility
[patent_app_number] => 11/917521
[patent_app_country] => US
[patent_app_date] => 2006-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 76163
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11917521
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917521 | Anti-cancer combination treatment and kit-of-parts | Jun 13, 2006 | Issued |
Array
(
[id] => 5479545
[patent_doc_number] => 20090202502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'HEPATIC STELLATE CELL SPECIFIC PROMOTER AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/916987
[patent_app_country] => US
[patent_app_date] => 2006-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10507
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202502.pdf
[firstpage_image] =>[orig_patent_app_number] => 11916987
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/916987 | Hepatic stellate cell specific promoter and uses thereof | Jun 8, 2006 | Issued |
Array
(
[id] => 5393642
[patent_doc_number] => 20090210955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'SHRNA AND SIRNA EXPRESSION IN A LIVING ORGANISM UNDER CONTROL OF A CODON-OPTIMIZED REPRESSOR GENE'
[patent_app_type] => utility
[patent_app_number] => 11/912451
[patent_app_country] => US
[patent_app_date] => 2006-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9423
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20090210955.pdf
[firstpage_image] =>[orig_patent_app_number] => 11912451
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/912451 | SHRNA AND SIRNA EXPRESSION IN A LIVING ORGANISM UNDER CONTROL OF A CODON-OPTIMIZED REPRESSOR GENE | Jun 7, 2006 | Abandoned |
Array
(
[id] => 6254930
[patent_doc_number] => 20100028997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'Method for culturing mesenchymal stem cell and method for producing biological tissue prosthesis'
[patent_app_type] => utility
[patent_app_number] => 11/919303
[patent_app_country] => US
[patent_app_date] => 2006-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8039
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028997.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919303
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919303 | Method for culturing mesenchymal stem cell and method for producing biological tissue prosthesis | May 8, 2006 | Issued |
Array
(
[id] => 5677876
[patent_doc_number] => 20060183232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Packaging cells for recombinant adenovirus'
[patent_app_type] => utility
[patent_app_number] => 11/384850
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 16143
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183232.pdf
[firstpage_image] =>[orig_patent_app_number] => 11384850
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/384850 | Packaging cells for recombinant adenovirus | Mar 19, 2006 | Issued |
Array
(
[id] => 5391694
[patent_doc_number] => 20090209007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Method of Expression Cloning in a Host Cell'
[patent_app_type] => utility
[patent_app_number] => 11/886585
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 21908
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209007.pdf
[firstpage_image] =>[orig_patent_app_number] => 11886585
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/886585 | Method of Expression Cloning in a Host Cell | Mar 19, 2006 | Abandoned |
Array
(
[id] => 4999267
[patent_doc_number] => 20070041901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Stabilized aptamers to PSMA and their use as prostate cancer therapeutics'
[patent_app_type] => utility
[patent_app_number] => 11/370491
[patent_app_country] => US
[patent_app_date] => 2006-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 40128
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20070041901.pdf
[firstpage_image] =>[orig_patent_app_number] => 11370491
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/370491 | Stabilized aptamers to PSMA and their use as prostate cancer therapeutics | Mar 6, 2006 | Issued |
Array
(
[id] => 5585970
[patent_doc_number] => 20090105172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Stabilized Aptamers to PSMA and Their Use as Prostate Cancer Therapeutics'
[patent_app_type] => utility
[patent_app_number] => 11/885908
[patent_app_country] => US
[patent_app_date] => 2006-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 39891
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105172.pdf
[firstpage_image] =>[orig_patent_app_number] => 11885908
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/885908 | Stabilized Aptamers to PSMA and Their Use as Prostate Cancer Therapeutics | Mar 6, 2006 | Abandoned |
Array
(
[id] => 8956241
[patent_doc_number] => 08502016
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-08-06
[patent_title] => 'Genomic alpha synuclein transgenic animal'
[patent_app_type] => utility
[patent_app_number] => 11/352403
[patent_app_country] => US
[patent_app_date] => 2006-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7830
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11352403
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/352403 | Genomic alpha synuclein transgenic animal | Feb 9, 2006 | Issued |
Array
(
[id] => 5154401
[patent_doc_number] => 20070037284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Vectors for expressing exogenous gene or exogenous nucleic acid sequences'
[patent_app_type] => utility
[patent_app_number] => 11/285757
[patent_app_country] => US
[patent_app_date] => 2005-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19502
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037284.pdf
[firstpage_image] =>[orig_patent_app_number] => 11285757
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/285757 | Vectors for expressing exogenous gene or exogenous nucleic acid sequences | Nov 21, 2005 | Abandoned |
Array
(
[id] => 8114751
[patent_doc_number] => 08158593
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-17
[patent_title] => 'GPR17 modulators, method of screening and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/665835
[patent_app_country] => US
[patent_app_date] => 2005-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7291
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/158/08158593.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665835
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665835 | GPR17 modulators, method of screening and uses thereof | Oct 16, 2005 | Issued |
Array
(
[id] => 4629644
[patent_doc_number] => 08008540
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'Transgenic non-human animal for use in research models for studying Parkinson\'s disease'
[patent_app_type] => utility
[patent_app_number] => 11/631729
[patent_app_country] => US
[patent_app_date] => 2005-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8293
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/008/08008540.pdf
[firstpage_image] =>[orig_patent_app_number] => 11631729
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/631729 | Transgenic non-human animal for use in research models for studying Parkinson's disease | Jul 6, 2005 | Issued |